Questions to Ask Before Starting Rexulti for Alzheimer’s

Five targeted questions help families weigh Rexulti's modest agitation benefit against stroke, death, and daily side-effect risks.

Before starting Rexulti for Alzheimer's, ask what it treats, how much it helps, what risks it carries, and how you will monitor and stop it. Rexulti is brexpiprazole, a daily antipsychotic pill for agitation linked to dementia due to Alzheimer's disease. Agitation here means restlessness, aggression, shouting, or resisting care tied to Alzheimer's dementia. These questions help families and clinicians weigh a modest benefit against serious safety limits.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

What is Rexulti approved for — and not for?

The U.S. Food and Drug Administration approved Rexulti on May 11, 2023 as the first drug for agitation associated with dementia due to Alzheimer's disease, based on two 12-week trials in patients ages 51-90, according to the FDA approval notice. That approval is narrow. It does not cover memory loss, confusion, or general dementia behavior. The drug label also carries a boxed warning that elderly patients with dementia-related psychosis treated with antipsychotics have higher risk of death.

It is not approved for dementia-related psychosis without Alzheimer's-related agitation. Ask the prescriber to state the exact target symptom in plain words. Ask whether another medical issue could explain the behavior. Pain, infection, dehydration, constipation, poor sleep, or a new drug can drive agitation. Treating that cause may remove the reason for Rexulti.

How much improvement is realistic?

In the confirmatory 12-week trial, caregivers rated about 5.3 points greater agitation reduction on the 29-item Cohen-Mansfield Agitation Inventory with brexpiprazole 2-3 mg than with placebo. That difference is real but modest, and it is the key limit to discuss before starting, as summarized on the current label page. Ask what success would look like for your family. Fewer outbursts, easier bathing and dressing, or safer evenings are clearer goals than a calmer score.

Set one or two observable goals and a review date. Also ask how long to try before judging. Daily use builds gradually during dose increases. It is not an as-needed sedative for a crisis moment.

What serious risks must you discuss first?

Ask about stroke and death risk in older adults with dementia. Labeling warns of cerebrovascular events including stroke, plus neuroleptic malignant syndrome, metabolic changes, abnormal movements, and strong compulsive urges such as gambling, shopping, eating, or sexual urges. Review the full drug and supplement list. Strong blockers of liver enzymes CYP3A4 or CYP2D6, and poor CYP2D6 metabolism, require dose changes.

Bring pharmacy and genetic test records if available. Ask who should avoid Rexulti or need extra caution. Prior stroke, mini-stroke, heart disease, diabetes, swallowing problems, low white-cell count, or Parkinson-like symptoms raise concern. A history of compulsive behavior also deserves direct discussion.

What side effects and daily checks should you plan?

The U.S. Food and Drug Administration reported common reactions in Alzheimer-agitation trials included headache, dizziness, urinary tract infection, nasal and throat irritation, and sleep disruption, according to the FDA approval notice. Dizziness and sleep disruption increase fall and injury risk. Ask for a fall, driving, and nighttime supervision plan. Watch for fever with muscle stiffness, trouble swallowing, extreme thirst or urination, sudden weakness, speech change, facial movements, restlessness, or new urges.

Seek prompt care for stroke signs, high fever, rigidity, confusion, or fainting. Keep a short daily log of sleep, falls, appetite, and behavior. Ask about labs and weight checks. Blood sugar, cholesterol, weight, blood pressure, and movement exams help catch metabolic and movement effects early. Clarify who orders them and how often.

How is it taken, and when do you pause or stop?

The approved Alzheimer-agitation titration is 0.5 mg daily on days 1-7, then 1 mg daily on days 8-14, then 2 mg daily from day 15, with a maximum of 3 mg daily after at least 14 more days based on response. Ask what to do after a missed dose and which drugs, alcohol, or sleep aids increase dizziness. Do not adjust the dose without the prescriber.

The Alzheimer's Association advises first asking what triggers the behavior and trying routine, environmental, and non-drug strategies, as described in its medications guidance. Useful steps to ask about include: Set a stop and review plan before the first pill. Ask when to return, what improvement keeps treatment going, and what side effect or lack of benefit stops it. Bring the behavior log and medication list to every visit.

  • keeping consistent wake, meal, bath, and bed times
  • lowering noise, clutter, bright light, and rushed transitions
  • offering toileting, water, food, pain relief, and rest before agitation peaks
  • using short calm phrases, one step at a time, plus music or a walk

You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.